205 related articles for article (PubMed ID: 22931590)
1. Dithiocarbamate complexes as radiopharmaceuticals for medical imaging.
Berry DJ; Torres Martin de Rosales R; Charoenphun P; Blower PJ
Mini Rev Med Chem; 2012 Oct; 12(12):1174-83. PubMed ID: 22931590
[TBL] [Abstract][Full Text] [Related]
2. One and two photon fluorescent complexes of rhenium and their technetium analogues.
Botchway S; Dilworth JR; Salichou M
Dalton Trans; 2010 Jun; 39(22):5219-20. PubMed ID: 20405059
[TBL] [Abstract][Full Text] [Related]
3. Differences between the macroscopic and tracer level chemistry of rhenium and technetium: contrasting cage isomerisation behaviour of Re(I) and Tc(I) carborane complexes.
Armstrong AF; Valliant JF
Dalton Trans; 2010 Sep; 39(35):8128-31. PubMed ID: 20694253
[TBL] [Abstract][Full Text] [Related]
4. Technetium and rhenium in five-coordinate symmetrical and dissymmetrical nitrido complexes with alkyl phosphino-thiol ligands. Synthesis and structural characterization.
Bolzati C; Cavazza-Ceccato M; Agostini S; Tisato F; Bandoli G
Inorg Chem; 2008 Dec; 47(24):11972-83. PubMed ID: 19007158
[TBL] [Abstract][Full Text] [Related]
5. Influence of ligand denticity on the properties of novel ⁹⁹mTc(I)-carbonyl complexes. Application to the development of radiopharmaceuticals for imaging hypoxic tissue.
Fernández S; Giglio J; Rey AM; Cerecetto H
Bioorg Med Chem; 2012 Jul; 20(13):4040-8. PubMed ID: 22658538
[TBL] [Abstract][Full Text] [Related]
6. Rhenium diazenide ternary complexes with dithiocarbamate ligands: towards new rhenium radiopharmaceuticals.
Cowley AR; Dilworth JR; Donnelly PS; Ross SJ
Dalton Trans; 2007 Jan; (1):73-82. PubMed ID: 17160176
[TBL] [Abstract][Full Text] [Related]
7. The role of coordination chemistry in the development of copper and rhenium radiopharmaceuticals.
Donnelly PS
Dalton Trans; 2011 Feb; 40(5):999-1010. PubMed ID: 21203624
[TBL] [Abstract][Full Text] [Related]
8. Contribution of electrospray mass spectrometry for the characterization, design, and development of nitrido technetium and rhenium heterocomplexes as potential radiopharmaceuticals.
Tisato F; Bolzati C; Porchia M; Refosco F
Mass Spectrom Rev; 2004; 23(5):309-32. PubMed ID: 15264232
[TBL] [Abstract][Full Text] [Related]
9. Techniques for Loading Technetium-99m and Rhenium-186/188 Radionuclides into Preformed Liposomes for Diagnostic Imaging and Radionuclide Therapy.
Goins B; Bao A; Phillips WT
Methods Mol Biol; 2017; 1522():155-178. PubMed ID: 27837538
[TBL] [Abstract][Full Text] [Related]
10. Characterisation via electrospray ionisation multistage mass spectrometry of three related series of nitrido technetium complexes containing phosphinothiolate and dithiocarbamate ligands.
Tubaro M; Traldi P; Bolzati C; Tisato F; Refosco F; Benini E; Cavazza-Ceccato M
Rapid Commun Mass Spectrom; 2005; 19(13):1874-80. PubMed ID: 15945035
[TBL] [Abstract][Full Text] [Related]
11. Radiometal complexes: characterization and relevant in vitro studies.
Jurisson S; Cutler C; Smith SV
Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):222-34. PubMed ID: 18480740
[TBL] [Abstract][Full Text] [Related]
12. Technetium Complexes and Radiopharmaceuticals with Scorpionate Ligands.
Martini P; Pasquali M; Boschi A; Uccelli L; Giganti M; Duatti A
Molecules; 2018 Aug; 23(8):. PubMed ID: 30111708
[TBL] [Abstract][Full Text] [Related]
13. Recent Research Trends on Bismuth Compounds in Cancer Chemoand Radiotherapy.
Kowalik M; Masternak J; Barszcz B
Curr Med Chem; 2019; 26(4):729-759. PubMed ID: 28971764
[TBL] [Abstract][Full Text] [Related]
14. Exploring Aqueous Coordination Chemistry of Highly Lewis Acidic Metals with Emerging Isotopes for Nuclear Medicine.
Whetter JN; Śmiłowicz D; Boros E
Acc Chem Res; 2024 Mar; 57(6):933-944. PubMed ID: 38501206
[TBL] [Abstract][Full Text] [Related]
15. Metal-dithiocarbamate complexes: chemistry and biological activity.
Hogarth G
Mini Rev Med Chem; 2012 Oct; 12(12):1202-15. PubMed ID: 22931592
[TBL] [Abstract][Full Text] [Related]
16. The hydrazide/hydrazone click reaction as a biomolecule labeling strategy for M(CO)3 (M = Re, (99m)Tc) radiopharmaceuticals.
Ganguly T; Kasten BB; Bučar DK; MacGillivray LR; Berkman CE; Benny PD
Chem Commun (Camb); 2011 Dec; 47(48):12846-8. PubMed ID: 22044929
[TBL] [Abstract][Full Text] [Related]
17. Click-to-Chelate: development of technetium and rhenium-tricarbonyl labeled radiopharmaceuticals.
Kluba CA; Mindt TL
Molecules; 2013 Mar; 18(3):3206-26. PubMed ID: 23481882
[TBL] [Abstract][Full Text] [Related]
18. A hexadentate bis(thiosemicarbazonato) ligand: rhenium(V), iron(III) and cobalt(III) complexes.
Paterson BM; White JM; Donnelly PS
Dalton Trans; 2010 Mar; 39(11):2831-7. PubMed ID: 20200709
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of new [Tc(N)(PS)]-based mixed-ligand compounds useful in the design of target-specific radiopharmaceuticals: the 2-methoxyphenylpiperazine dithiocarbamate derivatives as an example.
Bolzati C; Salvarese N; Carta D; Refosco F; Dolmella A; Pietzsch HJ; Bergmann R; Bandoli G
J Biol Inorg Chem; 2011 Jan; 16(1):137-55. PubMed ID: 20924624
[TBL] [Abstract][Full Text] [Related]
20. '2+1' Tricarbonyltechnetium(I) and -rhenium(I) mixed-ligand complexes with N-methylpyridine-2-carboxyamide and isocyanide or imidazole ligands-potential precursors of radiopharmaceuticals.
Fuks L; Gniazdowska E; Kozminski P; Lyczko M; Mieczkowski J; Narbutt J
Appl Radiat Isot; 2010 Jan; 68(1):90-5. PubMed ID: 19766012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
